Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Japan News/Yomiuri
The Japan News/Yomiuri
National
Yuto Yoshida and Yohei Takei / Yomiuri Shimbun Staff Writers

Shionogi to apply for approval of first Japan-made oral COVID drug

Shionogi & Co. President Isao Teshirogi speaks at a press conference in Chiyoda Ward, Tokyo, on Monday. (Credit: The Yomiuri Shimbun)

Japanese pharmaceutical company Shionogi & Co. plans to apply for government approval to sell its oral COVID-19 drug as early as next week, the company announced Monday.

If approved, it will be the first oral drug developed by a domestic company to treat COVID-19 patients.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.